Skip to main content
Log in

Gene Transfer Approaches to the Lysosomal Storage Disorders

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The work summarized in this paper used animal and cell culture models systems to develop gene therapy approaches for the lysosomal storage disorders. The results have provided the scientific basis for a clinical trial of gene transfer to hematopoietic stem cells (HSC) in Gaucher disease which is now in progress. The clinical experiment is providing evidence of HSC transduction, competitive engraftment of genetically corrected HSC, expression of the GC transgene, and the suggestion of a clinical response. In this paper we will review the progress made in Gaucher disease and include how gene transfer might be studied in other lysosomal storage disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Gieselmann, V., A. Polten, J. Kreysing, and K. von Figura. 1994. Molecular genetics of metachromatic leukodystrophy. J. Inher. Met. Dis. 17:500-509.

    Google Scholar 

  2. Kolodny, E.H. and A.L. Fluharty. 1995. Metachromatic Leukodystrophy and multiple sulfatase deficiency: sulfatase lipidosis. In Metabolic basis of inherited disease. Scriver Charles R., Beaudet Arthur L., Sly William S., and Valle David, editors. McGraw-Hill, New York, NY. 2693-2739.

    Google Scholar 

  3. Stein, C., V. Gieselmann, J.X. Kreysing, Schmidt B, R. Pohlmann, A. Waheed, H.E. Meyer, J.S. O'Brien, and K. von Figura. 1989. Cloning and expression of human arylsulfatase A.J. Biol. Chem. 264:1252-1259.

    Google Scholar 

  4. Kreysing, J., K. von Figura, and V. Gieselmann. 1990. Structure of the arylsulfatase A gene. Eur. J. Biochem. 191:627-631.

    Google Scholar 

  5. Kreysing, J., A. Polten, B. Hess, K. von Figura, K. Menz, F.X. Steiner, and V. Gieselmann. 1994. Structure of the mouse arylsulfatase A gene and cDNA. Genomics 19:249-256.

    Google Scholar 

  6. Polten, A., A.L. Fluharty, C.B. Fluharty, J. Kappler, K. von Figura, and V. Gieselmann. 1991. Molecular basis of different forms of metachromatic leukodystrophy. N. Engl. J. Med. 324:18-22.

    Google Scholar 

  7. Hess, B., P. Saftig, D. Hartmann, R. Coenen, R. Lullmann-Rauch, H.H. Goebel, K. von Figura, R. D'Hooge, G. Nagels, P. De Deyn, C. Peters, M. Evers, and V. Gieselmann. 1996. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc. Natl. Acad. Sci., USA 93:14821-14826.

    Google Scholar 

  8. Jinnah, H.A., F.H. Gage, and T. Friedmann. 1991. Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine hosphoribosyltransferase-deficient mouse model of L'esch-Nyhan syndrome. Behav. Neurosci. 105:1004-1012.

    Google Scholar 

  9. De Groot, C.J., W. Huppes, T. Sminia, G. Kraal, and C.D. Dijkstra. 1992. Determination of the origin and nature of brain macrophages and microglial cells in mouse central nervous system, using non-radioactive in situ hybridization and immunoperoxidase techniques. GLIA 6:301-309.

    Google Scholar 

  10. Unger, E.R., J.H. Sung, J.C. Manivel, M.L. Chenggis, B.R. Blazar, and W. Krivit. 1993. Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J. Neuropath. Exp. Neurol. 52:460-470.

    Google Scholar 

  11. Krall, W.J., P.M. Challita, L.S. Perlmutter, D.C. Skelton, and D.B. Kohn. 1994. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood 83:2737-2748.

    Google Scholar 

  12. Whitley, C.B., K.G. Belani, P.N. Chang. C.G. Summers, B.R.X. Blazar, Tsai MY, R.E. Latchaw, N.K. Ramsay, and J.H. Kersey. 1993. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am. J. Med. Genet. 46:209-218.

    Google Scholar 

  13. Bergstrom, S.K., J.J. Quinn, R. Greenstein, and J. Ascensao. 1994. Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review. Bone Marrow Transpl. 14:653-658.

    Google Scholar 

  14. Vellodi, A., E. Young, M. New, C. Pot-Mees, and K. Hugh-Jones. 1992. Bone marrow transplantation for Sanfilippo disease type B. J. Inher. Met. Dis. 15:911-918.

    Google Scholar 

  15. Krivit, W., E. Shapiro. W. Kennedy, M. Lipton, L. Lockman, S. Smith, C.G. Summers, D.A. Wenger, M.Y. Tsai, N.K. Ramsay, L.X. Lockman, and et al. 1990. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N. Engl. J. Med. 322:28-32.

    Google Scholar 

  16. Pridjian, G., J. Humbert, J. Willis, and E. Shapira. 1994. Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation. J. Pediatrics 125:755-758.

    Google Scholar 

  17. Birkenmeier, E.H. 1991. Correction of murine mucopolysaccharidosis type VII (MPS VII) by bone marrow transplantation and gene transfer therapy. Hum. Gene Therapy 2:113.

    Google Scholar 

  18. Marechal, V., N. Naffakh, O. Danos, and J.M. Heard. 1993. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood 82:1358-1365.

    Google Scholar 

  19. Moullier, P., D. Bohl, J.M. Heard, and O. Danos. 1993. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat. Genet. 4:154-159.

    Google Scholar 

  20. Bastedo, L., M.S. Sands, D.T. Lambert, M.A. Pisa, E. Birkenmeier, and P.L. Chang. 1994. Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII. J. Clin. Invest. 94:1180-1186.

    Google Scholar 

  21. Walkley, S.U., M.A. Thrall, K. Dobrenis, M. Huang, P.A. March, D.A. Siegel, and S. Wurzelmann. 1994. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc. Natl. Acad. Sci., USA 91:2970-2974.

    Google Scholar 

  22. Shull, R.M., N.E. Hastings, R.R. Selcer, J.B. Jones, J.R.X. Smith, Cullen WC, and G. Constantopoulos. 1987. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system. J. Clin. Invest. 79:435-443.

    Google Scholar 

  23. Taylor, R.M., G.J. Stewart, B.R. Farrow, Byrne, J, and P.J. Healy. 1989. Histological improvement and enzyme replacement in the brains of fucosidosis dogs after bone marrow engraftment. Transpl. Proc. 21:3074-3075.

    Google Scholar 

  24. Birkenmeier, E.H., J.E. Barker, C.A. Vogler, J.W. Kyle, W.S.X. Sly, Gwynn B, B. Levy, and C. Pegors. 1991. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 78:3081-3092.

    Google Scholar 

  25. Leinekugel, P., S. Michel, E. Conzelmann, and K. Sandhoff. 1992. Quantitative correlation between the residual activity of beta-hexosaminidase. A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum. Genet. 88:513-523.

    Google Scholar 

  26. Sands, M.S., J.E. Barker, C. Vogler, B. Levy, B. Gwynn, Galvin, N, W.S. Sly, and E. Birkenmeier. 1993. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest. 68:676-686.

    Google Scholar 

  27. Will, A., A. Cooper, C. Hatton, I.B. Sardharwalla, D.I. Evans, and R.F. Stevens. 1987. Bone marrow transplantation in the treatment of alpha-mannosidosis. Arch. Dis. Childh 62:1044-1049.

    Google Scholar 

  28. Havenga M., Hoogerbrugge P., Valerio D., and van Es H.H.G. 1997. Retroviral stem cell gene therapy. Stem Cells 15:162-179.

    Google Scholar 

  29. Ohashi, T., S. Boggs, P. Robbins, A. Bahnson, K. Patrene, Wei, FS, J.F. Wei, J. Li, L. Lucht, Y. Fei, and et al. 1992. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc. Natl. Acad. Sci., USA 89:11332-11336.

    Google Scholar 

  30. Correll, P.H., S. Colilla, and S. Karlsson. 1994. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo. Blood 6:1812-1822.

    Google Scholar 

  31. Moore, K.A., A.B. Deisseroth, C.L. Reading, D.E. Williams, and J.W. Belmont. 1992. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79:1393-1399.

    Google Scholar 

  32. Szilvassy, S.J. and S. Cory. 1994. Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood 84:74-83.

    Google Scholar 

  33. Mannion-Henderson, J., A. Kemp, M. Nimgaonkar, J. Lancia, M. Beeler, J. Mierski, A.B. Bahnson, E.D. Ball, and J.A. Barranger. 1995. Efficient retroviral mediated transfer of the glucocerebrosidase gene in CD34+ enriched umbilical cord blood human hematopoietic progenitors. Exp. Hematol. 23:1628-1632.

    Google Scholar 

  34. Nolta, J.A., E.M. Smogorzewska, and D.B. Kohn. 1995. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101-110.

    Google Scholar 

  35. Xu, L.C., S. Kluepfel-Stahl, M. Blanco, R. Schiffmann, C. Dunbar, and S. Karlsson. 1995. Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34+ cells from Gaucher patients. Blood 86:141-146.

    Google Scholar 

  36. Dunbar, C.E., D.M. Bodine, B. Sorrentino, R. Donahue, McDonagh, K, M. Cottler-Fox, J. O'Shaughnessy, K. Cowan, C. Carter, S. Doren, and et al. 1994. Gene transfer into hematopoietic cells. Implications for cancer therapy. Ann. NY Acad. Sci. 716:216-24.

    Google Scholar 

  37. Bahnson, A.B., J.T. Dunigan, Baysal B.E., Mohney T., Atchison R.W., M.T. Nimgaonkar, E.D. Ball, and J.A. Barranger. 1995. Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Meth. 54:131-143.

    Google Scholar 

  38. Nishino, H., T. Hashitani, M. Kumazaki, H. Sato, F.X. Furuyama, Isobe Y, N. Watari, M. Kanai, and S. Shiosaka. 1990. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway. Brain Res. 534:83-93.

    Google Scholar 

  39. Madrazo, I. and R. Franco-Bourland. 1990. A brain transplant that works. Lancet 335:1283.

    Google Scholar 

  40. Madrazo, I., R. Franco-Bourland, F. Ostrosky-Solis, Aguilera, M, C. Cuevas, C. Zamorano, A. Morelos, E. Magallon, and G. Guizar-Sahagun. 1990. Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects. Arch. Neurol. 47:1281-1285.

    Google Scholar 

  41. Madrazo, I., V. Leon, C. Torres, M.C. Aguilera, G.X. Varela, Alvarez F, A. Fraga, R. Drucker-Colin, F. Ostrosky, M. Skurovich, and et al. 1988. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N. Engl. J. Med. 318:51.

    Google Scholar 

  42. Sawle, G.V., P.M. Bloomfield, A. Bjorklund, D.J. Brooks, Brundin, P, K.L. Leenders, O. Lindvall, C.D. Marsden, S.X. Rehncrona, Widner H, and et al. 1992. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann. Neurol. 31:166-173.

    Google Scholar 

  43. Lindvall, O., H. Widner, S. Rehncrona, P. Brundin, P.X. Odin, Gustavii B, R. Frackowiak, K.L. Leenders, G. Sawle, Rothwell, JC, and et al. 1992. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155-165.

    Google Scholar 

  44. Lindvall, O., P. Brundin, H. Widner, S. Rehncrona, Gustavii, B, R. Frackowiak, K.L. Leenders, G. Sawle, J.C.X. Rothwell, Marsden CD, and et al. 1990. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577.

    Google Scholar 

  45. Lindvall, O., S. Rehncrona, P. Brundin, B. Gustavii, Astedt, B, H. Widner, T. Lindholm, A. Bjorklund, K.L. Leenders, J.C. Rothwell, and et al. 1990. Neural transplantation in Parkinson's disease: the Swedish experience. Prog. Brain Res. 82:729-734.

    Google Scholar 

  46. Lindvall, O., S. Rehncrona, P. Brundin, B. Gustavii, Astedt, B, H. Widner, T. Lindholm, A. Bjorklund, K.L. Leenders, J.C. Rothwell, and et al. 1989. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46:615-631.

    Google Scholar 

  47. Rosenbluth, J., M. Hasegawa, N. Shirasaki, C.L. Rosen, and Z. Liu. 1990. Myelin formation following transplantation of normal fetal glia into myelin-deficient rat spinal cord. J. Neurocyt. 19:718-730.

    Google Scholar 

  48. Gansmuller, A., Lachapelle F., Baron-Van Evercooren A., Hauw JJ., Baumann N., and M. Gumpel. 1986. Transplantation of newborn CNS fragments into the brain of Shiverer mutant mice: extensive myelination by transplanted oligodendrocytes. Electron microscopic study. Dev. Neurosci. 8:197-207.

    Google Scholar 

  49. Lubetzki, C., A. Gansmuller, F.X. Lachapelle, Lombrail P, and M. Gumpel. 1988. Myelination by oligodendrocytes isolated from 4-6-week-old rat central nervous system and transplanted into newborn shiverer brain. J. Neurol. Sci. 88:161-175.

    Google Scholar 

  50. Gumpel, M., F. Lachapelle, A.X. Gansmuller, Baulac M, A. Baron van Evercooren, and N. Baumann. 1987. Transplantation of human embryonic oligodendrocytes into shiverer brain. Ann. NY Acad. Sci. 495:71-85.

    Google Scholar 

  51. Archer, D.R., S. Leven, and I.D. Duncan. 1994. Myelination by cryopreserved xenografts and allografts in the myelin-deficient rat. Exp. Neurol. 125:268-277.

    Google Scholar 

  52. Noble, M. 1994. The O-2A lineage: from rats to humans. Rec Res Can Res 135:67-75.

    Google Scholar 

  53. Dubois-Dalcq, M. and R.C. Armstrong. 1992. the oligodendrocyte lineage during myelination and remyelination. In Myelin: biology and chemistry. Martenson Russell E. editor. CRC press, Boca Raton, FL. 81-122.

    Google Scholar 

  54. Temple, S. and M.C. Raff. 1985. Differentiation of a bipotential glial progenitor cell in a single cell microculture. Nature 313:223-225.

    Google Scholar 

  55. Miller, R.H., S. David, R. Patel, E.R. Abney, and M.C. Raff. 1985. A quantitative immunohistochemical study of microglial cell development in the rat optic nerve: in vivo evidence for two distinct astrocyte lineages. Dev. Biol. 111:35-41.

    Google Scholar 

  56. McMorris, F.A. and M. Dubois-Dalcq. 1988. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J. Neurosci. Res. 21:199-209.

    Google Scholar 

  57. Noble, M., K. Murray, P. Stroobant, M.D. Waterfield, and P. Riddle. 1988. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560-562.

    Google Scholar 

  58. Lillien LE., Sendtner M., and M.C. Raff. 1990. Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocytes development. J. Cell Biol. 111:635-644.

    Google Scholar 

  59. McKinnon, R.D., T. Matsui, M. Dubois-Dalcq, and S.A. Aaronson. 1990. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron. 5:603-614.

    Google Scholar 

  60. Bogler, O., D. Wren, S.C. Barnett, H. Land, and M. Noble. 1990. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci., USA 87:6368-6372.

    Google Scholar 

  61. Benveniste, E.N. and J.E. Merrill. 1986. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 321:610-613.

    Google Scholar 

  62. Bottenstein, J.E., S.F. Hunter, and M. Seidel. 1988. CNS neuronal cell line-derived factors regulate gliogenesis in neonatal rat brain cultures. J. Neurosci. Res. 20:291-303.

    Google Scholar 

  63. Bottenstein, J.E. and Hunter S. 1990. culture methods for oligodendrocyte-type 2 astrocyte lineage cells. In cell culture. Conn MP, editor. academic press, San Diego. 56-75.

    Google Scholar 

  64. Baulac, M., F. Lachapelle, O. Gout, B. Berger, N. Baumann, and M. Gumpel. 1987. Transplantation of oligodendrocytes in the newborn mouse brain: extension of myelination by transplanted cells. Anatomical study. Brain Res. 420:39-47.

    Google Scholar 

  65. Gansmuller, A., E. Clerin, F. Kruger, M. Gumpel, and F. Lachapelle. 1991. Tracing transplanted oligodendrocytes during migration and maturation in the shiverer mouse brain. GLIA 4:580-590.

    Google Scholar 

  66. Groves, A.K., S.C. Barnett, R.J. Franklin, A.J. Crang, M. Mayer, W.F. Blakemore, and M. Noble. 1993. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362:453-455.

    Google Scholar 

  67. Lachapelle, F., E. Duhamel-Clerin, A. Gansmuller, A.X. Baron-Van Evercooren, Villarroya H, and M. Gumpel. 1994. Transplanted transgenically marked oligodendrocytes survive, migrate and myelinate in the normal mouse brain as they do in the shiverer mouse brain. Eur. J. Neurosci 6:814-824.

    Google Scholar 

  68. Louis, J.C., E. Magal, D. Muir, M. Manthorpe, and S. Varon. 1992. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J. Neurosci. Res. 31:193-204.

    Google Scholar 

  69. Tontsch, U., D.R. Archer, M. Dubois-Dalcq, and I.D. Duncan. 1994. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc. Natl. Acad. Sci., USA 91:11616-11620.

    Google Scholar 

  70. Avellana-Adalid, V., B. Nait-Oumesmar, F. Lachapelle, and A. Baron-Van Evercooren. 1996. Expansion of rat oligodendrocyte progenitors into proliferative “oligospheres” that retain differentiation potential. J. Neurosci. Res. 45:558-570.

    Google Scholar 

  71. Snyder, E.Y., D.L. Deitcher, C. Walsh, S.X. Arnold-Aldea, Hartwieg EA, and C.L. Cepko. 1992. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33-51.

    Google Scholar 

  72. Snyder, E.Y., R.M. Taylor, and J.H. Wolfe. 1995. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374:367-370.

    Google Scholar 

  73. Phillips, M.I. 1997. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 29:177-187.

    Google Scholar 

  74. Hargrove, P.W., E.F. Vanin, G.J. Kurtzman, and A.W. Nienhuis. 1997. High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3' Y globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 6:2167-2175.

    Google Scholar 

  75. Weitzman, M.D., S.R. Kyostio, R.M. Kotin, and R.A. Owens. 1994. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci., USA 91:5808-5812.

    Google Scholar 

  76. Chiorini, J.A., L. Yang, B. Safer, and R.M. Kotin. 1995. Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. J. Virol. 69:7334-7338.

    Google Scholar 

  77. Giraud, C., E. Winocour, and K.I. Berns. 1995. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 69:6917-6924.

    Google Scholar 

  78. Urcelay, E., P. Ward, S.M. Wiener, B. Safer, and R.M. Kotin. 1995. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 69:2038-2046.

    Google Scholar 

  79. Walsh, C.E., J.M. Liu, X. Xiao, N.S. Young, A.W. Nienhuis, and R.J. Samulski. 1992. Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci., USA 89:7257-7261.

    Google Scholar 

  80. Fisher, K.J., G.P. Gao, M.D. Weitzman, R. DeMatteo, J.F. Burda, and J.M. Wilson. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:520-532.

    Google Scholar 

  81. Ferrari, F.K., T. Samulski, T. Shenk, and R.J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.

    Google Scholar 

  82. Vincent, K.A., S.T. Piraino, and S.C. Wadsworth. 1997. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol. 71:1897-1905.

    Google Scholar 

  83. Mamounas, M., M. Leavitt, M. Yu, and F. Wong-Staal. 1995. Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. Gene Therapy 2:429-432.

    Google Scholar 

  84. Chiorini, J.A., C.M. Wendtner, E. Urcelay, B. Safer, M. Hallek, and R.M. Kotin. 1995. High-efficiency transfer of the T cell costimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene. Therapy 6:1531-1541.

    Google Scholar 

  85. Clark, K.R., F. Voulgaropoulou, D.M. Fraley, and P.R. Johnson. 1995. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene. Therapy 6:1329-1341.

    Google Scholar 

  86. Kaplitt, M.G., P. Leone, R.J. Samulski, X. Xiao, D.W. Pfaff, K.L. O'Malley, During, MJ. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.

    Google Scholar 

  87. Poduslo, S.E., G. Tennekoon, D. Price, K. Miller, and G.M. McKhann. 1976. Fetal metachromatic leukodystrophy: pathology, biochemistry and a study of in vitro enzyme replacement in CNS tissue. J. Neuropath. Exp. Neurol. 35:622-632.

    Google Scholar 

  88. Baier, W. and K. Harzer. 1983. Sulfatides in prenatal metachromatic leukodystrophy. J. Neurochem. 41:1766-1768.

    Google Scholar 

  89. Adachi, M., L. Schneck, and B.W. Volk. 1974. Ultrastructural studies of eight cases of fetal Tay-Sachs disease. Lab. Invest. 30:102-112.

    Google Scholar 

  90. Kaye, E.M., M.D. Ullman, E.R. Wilson, and J.A. Barranger. 1986. Type 2 and type 3 Gaucher disease: a morphological and biochemical study. Ann. Neurol. 20:223-230.

    Google Scholar 

  91. Schneider, E.L., W.G. Ellis, R.O. Brady, J.R. McCulloch, Epstein, CJ. 1972. Infantile (type II) Gaucher's disease: in utero diagnosis and fetal pathology. J. Pediatr. 81:1134-1139.

    Google Scholar 

  92. Kamoshita, S., M. Odwara, M. Yoshida, M. Owada, and T. Kitagawa. 1976. Fetal pathology and ultrastructure of neuronopathic Gaucher's disease. In Current Trends in Sphingolipidoses and Allied Disorders. B.W. Volk and L. Schneck, editors. Plenum press, New York, 327

    Google Scholar 

  93. Sidransky, E., D.M. Sherer, and E.I. Ginns. 1992. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. [Review] [30 refs]. Pediatric. Res. 32:494-498.

    Google Scholar 

  94. Metcalf, D. and M.A.S. Moore. 1971. Embryonic aspects of haemopoiesis. In Frontiers of Biology-Haematopoietic Cells. A. Neuberger and E.L. Tatum, editors. Amsterdam, North Holland Publishing Co. Amsterdam. pp172

    Google Scholar 

  95. O'Reilly, R.J., M.S. Pollack, N. Kapoor, and et al. 1983. Fetal liver transplantation in man and animals. In Recent advances in bone marrow transplantation. R.G. Gale, editor. Alan R Liss, Inc., New York. pp779

    Google Scholar 

  96. Salami, M.A., M.W. Simpson-Morgan, and B. Morris. 1985. Haemopoiesis and the development of immunologic reactivity in the sheep fetus. In Immunology of the sheep. Anonymous-Editiones Roche, Basil, Switzerland. pp19

  97. Wu, A.M., J.E. Till, L. Siminovitch, and E.A. McCulloch. 1968. Cytological evidence for a relationship between normal hemotopoietic colony-forming cells and cells of the lymphoid system. J. Exp. Med. 127:455-464.

    Google Scholar 

  98. Lowenberg, B., K.A. Dicke, D.W. van Bekkum, and L.J. Dooren. 1976. Quantitative aspects of fetal liver cell transplantation in animals and man. Transpl. Proc. 8:527-532.

    Google Scholar 

  99. Ekhterae, D., T. Crumbleholme, E. Karson, M.R.X. Harrison, Anderson WF, and E.D. Zanjani. 1990. Retroviral vector-mediated transfer of the bacterial neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitro. Blood 75:365-369.

    Google Scholar 

  100. Rosenthal, P., I.J. Rimm, T. Umiel, J.D. Griffin, Osathanondh, R, S.F. Schlossman, and L.M. Nadler. 1983. Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies. J. Immunol. 131:232-237.

    Google Scholar 

  101. Lapidot, T., F. Pflumio, M. Doedens, B. Murdoch, D.E. Williams, and J.E. Dick. 1992. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137-1141.

    Google Scholar 

  102. Turner, J.H., D.L. Hutchinson, and J.C. Petricciani. 1973. Chimerism following fetal transfusion. Report of leukocyte hybridization and infant with acute lymphocyte leukemia. Scand. J. Hematol. 10:358-366.

    Google Scholar 

  103. Szymanski, I.O., C.A. Tilley, M.C. Crookston, and T.J.X. Greenwalt, Moore S. 1977. A further example of human blood group Chimerism. J. Med. Genet. 14:279-281.

    Google Scholar 

  104. Billingham, R.E., L. Brent, and P.B. Medawai. 1953. Actively acquired tolerance of foreign cells. Nature 172:603-606.

    Google Scholar 

  105. Binns, R.M. 1967. Bone marrow and lymphoid cell injection of the pig fetus resulting in transplantation tolerance or immunity, and immunoglobulin production. Nature 214:179-180.

    Google Scholar 

  106. Roncarolo, M.G. and B. Vandekerckhove. 1992. SCID-hu mice as a model to study tolerance after fetal stem cell transplantation. Bone Marrow Transpl. 9Suppl 1:83-84.

    Google Scholar 

  107. Touraine, J.L., M.G. Roncarolo, R. Bacchetta, D.X. Raudrant, Rebaud A, S. Laplace, P. Cesbron, L. Gebuhrer, M.T.X. Zabot, Touraine F, and et al. 1993. Fetal liver transplantation: biology and clinical results [Review] [5 refs]. Bone Marrow Transpl. 11Suppl 1:119-122.

    Google Scholar 

  108. Wolfe, J.H., M.S. Sands, J.E. Barker, B. Gwynn, L.B. Rowe, C.A. Vogler, and E.H. Birkenmeier, 1992. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature 360:749-753.

    Google Scholar 

  109. Bansal, V., P. Mowery-Rushton, L. Lucht, J. Li, A.X. Bahnson, Watkins SC, and J.A. Barranger. 1994. Transduction, expression, and secretion of human glucocerebrosidase by murine myoblasts. Ann. NY Acad. Sci. 716:307-19.

    Google Scholar 

  110. Danos, O. and R.C. Mulligan. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci., USA 85:6460-6464.

    Google Scholar 

  111. Miller, A.D. and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.

    Google Scholar 

  112. Ohashi, T., Y. Eto, R. Learish, and J.A. Barranger. 1993. Correction of enzyme deficiency in metachromatic leukodystrophy fibroblasts by retroviral-mediated transfer of the human arylsulphatase A gene. J. Inher. Met. Dis. 16:881-885.

    Google Scholar 

  113. Learish, R., T. Ohashi, P.A. Robbins, A. Bahnson, S.S. Boggs, K.X. Patrene, Schwartz BE, V. Gieselmann, and J.A. Barranger. 1996. Retroviral gene transfer and sustained expression of human arylsulfatase A. Gene Therapy 3:343-349.

    Google Scholar 

  114. Wei, J.F., F.S. Wei, R.J. Samulski, and J.A. Barranger. 1994. Expression of the human glucocerebrosidase and arylsulfatase A genes in murine and patient primary fibroblasts transduced by an adeno-associated virus vector. Gene Therapy 1:261-268.

    Google Scholar 

  115. Scott, J.E., C.R. Orford, and E.W. Hughes. 1981. Proteoglycan-collagen arrangements in developing rat tail tendon. An electron microscopical and biochemical investigation. Biochem. J. 195:573-581.

    Google Scholar 

  116. Walkley, S.U., M.A. Thrall, K. Dobrenis, P. March, and S. Wurzelmann. 1994. Bone marrow transplantation in neuronal storage diseases. Brain Pathol 4:376

    Google Scholar 

  117. Dobrenis, K., D.A. Wenger, and S.U. Walkley. 1994. Extracellular release of lysosomal glycosidases in culture of cat microglia. Mol. Biol. cell 5:113A

    Google Scholar 

  118. Perry, V.H. 1994. Macrophages and the nervous system. Austin: R G Landes Company, 6 pp.

    Google Scholar 

  119. Eppig, J.J., L.P. Kozak, E.M. Eicher, and L.C. Stevens. 1977. Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division. Nature 269:517-518.

    Google Scholar 

  120. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.

    Google Scholar 

  121. Neuwelt, E.A., J.A. Barranger, M.A. Pagel, J.M. Quirk, R.O.X. Brady, and E.P. Frenkel. 1984. Delivery of active hexosaminidase across the blood-brain barrier in rats. Neurology 34:1012-1019.

    Google Scholar 

  122. Hickey, W.F. and H. Kimura. 1982. Perivascular microglia cells of the CNS are bone marrow derived and present antigens in vivo. Science 239:290-292.

    Google Scholar 

  123. Bartlett, P.F. 1982. Pluripotential hemopoietic stem cells in adult mouse brain. Proc. Natl. Acad. Sci., USA 79:2722-2725.

    Google Scholar 

  124. Bayever, E., S. Ladisch, M. Philippart, N. Brill, M.X. Nuwer, Sparkes RS, and S.A. Feig. 1985. Bone-marrow transplantation for metachromatic leukodystrophy. Lancet 2:471-473.

    Google Scholar 

  125. Hobbs, J.R. 1985. Correction of 34 genetic diseases by displacement bone marrow transplantation. Plasma Ther. transfus Technol. 6:221-246.

    Google Scholar 

  126. Taylor, R.M., B.R.L. Farrow, G.J. Steward, P.J. Healy, and K. Tivier. 1987. Lysosomal enzyme replacement in neural tissue by allogeneic bone marrow transplantation following total lymphoid irradiation in canine fucosidisis. Transplant. Proc. 19:2730-2734.

    Google Scholar 

  127. Hoogerbrugge, P.M., B.J.H.M. Poorthuis, J.M.J.J. Vossen, L.J. Dooren, G. Wagenmaker, and D.W. van Bekkum. 1987. Bone marrow transplantation in murine lysosomal storage disease. Exp. Hematol. 15:616a

    Google Scholar 

  128. Schull, R.M., M.A. Breider, and G.C. Constantopulos. 1988. Long-term neurological effects of bone marrow transplantation in a canine lysosomal storage disease. Pediatric Res. 24:347-352.

    Google Scholar 

  129. Mowery-Rushton, P.A., L. Lucht, J. Li, M.J. Vallor, Bansal, V, and J.A. Barranger. 1993. Expression of glucocerebrosidase in the brain following transplantation of transduced bone marrow in mice. Society of Pediatric Research, Washington, D.C. Abstract.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barranger, J.A., Rice, E.O. & Swaney, W.P. Gene Transfer Approaches to the Lysosomal Storage Disorders. Neurochem Res 24, 601–615 (1999). https://doi.org/10.1023/A:1022548232735

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022548232735

Navigation